author-photo

Shigang Xiong

University of Southern California

52

Papers

2951

Citations

Citation Trend

Filter By

Papers (52) Sort By

Journal Conference Others

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer

2019 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Final results from a trial of a combination herbal supplement for biochemically recurrent prostate cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase II Trial of AEZS-108 in Castration- and Taxane-Resistant Prostate Cancer

2017 Clinical Genitourinary Cancer
Show All
- Source
- Cite
- Save
Citations (18)
Endoglin (CD105) expression in non-seminomatous germ cell tumors.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A phase I dose-escalation trial of AEZS-108 in taxane- and castration-resistant prostate cancer (CRPC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A phase II trial of zoptarelin doxorubicin in castration- and taxane-resistant prostate cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
B in Kupffer cells κ Iron activates NF

2016
Show All
- Source
- Cite
- Save
Citations (0)
2539 A phase II trial of AEZS-108 in castration and taxane resistant prostate cancer

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Effects of luteinizing hormone receptor signaling in prostate cancer cells

2015 The Prostate
Show All
- Source
- Cite
- Save
Citations (10)
A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer

2014 Prostate Cancer and Prostatic Diseases
Show All
- Source
- Cite
- Save
Citations (8)